RETRACTED ARTICLE: The Value of U-Ngal Expression as a Potential Prognostic Biomarker in Patients With Renal Cancer After Neoadjuvant Chemotherapy With Cisplatin

Tumor Biology - United States
doi 10.1007/s13277-015-3680-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Value of NGAL Staining in Patients With IgA Nephropathy

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2013English

Pretreatment Systemic Inflammation Response Index in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

Cancer Management and Research
Oncology
2020English

PD-L1 Expression of the Residual Tumor Serves as a Prognostic Marker in Local Advanced Breast Cancer After Neoadjuvant Chemotherapy

International Journal of Cancer
Cancer ResearchOncology
2017English

Identification of a Three miRNA Signature as a Novel Potential Prognostic Biomarker in Patients With Blaader Cancer

Oncotarget
Oncology
2017English

Identification of F5 as a Prognostic Biomarker in Patients With Gastric Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

Evaluation of Prognostic Factors and Validation of Tumor Response Ratios After Neoadjuvant Chemotherapy in Patients With Breast Cancer

Journal of Breast Disease
2016English

Mp58-07 Use of Adjuvant Chemotherapy in Patients With Advanced Bladder Cancer After Neoadjuvant Chemotherapy

Journal of Urology
Urology
2017English

CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2018English

Upregulation of WEE1 Is a Potential Prognostic Biomarker for Patients With Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy